Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis (Q82397612)

From Wikidata

Jump to navigation Jump to search

scientific article published on 05 January 2010

Language	Label	Description	Also known as
English	Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis	scientific article published on 05 January 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Hisashi Yamanaka

9

object named as

Hisashi Yamanaka

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Kumi Shidara

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Eisuke Inoue

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Eiichi Tanaka

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Daisuke Hoshi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yohei Seto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ayako Nakajima

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shigeki Momohara

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Atsuo Taniguchi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

5 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rheumatology International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

617-622

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20049446%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-keratin antibodies in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis a

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Very recent onset arthritis: the value of initial rheumatologist evaluation and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted ultrasound of the fifth metatarsophalangeal joint in an early inflammatory arthritis cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Organization, structure, and polymorphisms of the human profilaggrin gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20049446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82397612&oldid=2221241363"